Tilray Signs Global Collaboration Agreement With Leading Pharmaceutical Company

working-at-sandoz

CANADA: Tilray Canada, a subsidiary of Tilray, a global pioneer in the production, research, and distribution of medical cannabis, announced today that it entered into a global framework agreement to collaborate with C, a global leader in generic pharmaceuticals and biosimilars and a part of Novartis group, to increase availability of high quality medical cannabis products Read the full article…

Tilray Forms Strategic Alliance With Leading Pharmaceutical Company In Canada

Tilray_Logo

CANADA: Tilray, a federally licensed producer of medical cannabis, announced today that it has signed a binding letter of intent (LOI) to be the exclusive collaborator of a major pharmaceutical company to accelerate innovation and increase availability of high quality medical cannabis products. Through this LOI and the anticipated definitive agreements, Tilray is allied with Sandoz Read the full article…